BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang X, Zhang Q, Guan B. Circ_0110805 Knockdown Enhances Cisplatin Sensitivity and Inhibits Gastric Cancer Progression by miR-299-3p/ENDOPDI Axis. Onco Targets Ther 2020;13:11445-57. [PMID: 33192077 DOI: 10.2147/OTT.S279563] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Loren P, Saavedra N, Saavedra K, De Godoy Torso N, Visacri MB, Moriel P, Salazar LA. Contribution of MicroRNAs in Chemoresistance to Cisplatin in the Top Five Deadliest Cancer: An Updated Review. Front Pharmacol 2022;13:831099. [PMID: 35444536 DOI: 10.3389/fphar.2022.831099] [Reference Citation Analysis]
2 Zhang X, Dai X, Zhao X, Wang J, Dou J, Zhuang H, Chen N, Zhao H. MiR-874-3p represses the migration and invasion yet promotes the apoptosis and cisplatin sensitivity via being sponged by long intergenic non-coding RNA 00922 (LINC00922) and targeting Glycerophosphodiester Phosphodiesterase Domain Containing 5 (GDPD5) in gastric cancer cells. Bioengineered 2022;13:7082-104. [PMID: 35282764 DOI: 10.1080/21655979.2022.2045831] [Reference Citation Analysis]
3 Wang H, Shan S, Wang H, Wang X. CircATXN7 contributes to the progression and doxorubicin resistance of breast cancer via modulating miR-149-5p/HOXA11 pathway. Anticancer Drugs 2022;33:e700-10. [PMID: 34845164 DOI: 10.1097/CAD.0000000000001243] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
4 Tai Y, Li Y, Zhang M. Silencing of circ_OSBPL10 affects the functional behaviors of oral squamous cell carcinoma cells by the miR-299-3p/CDK6 axis. Archives of Oral Biology 2022. [DOI: 10.1016/j.archoralbio.2022.105363] [Reference Citation Analysis]
5 Zhang R, Zhao H, Yuan H, Wu J, Liu H, Sun S, Zhang Z, Wang J. CircARVCF Contributes to Cisplatin Resistance in Gastric Cancer by Altering miR-1205 and FGFR1. Front Genet 2021;12:767590. [PMID: 34899853 DOI: 10.3389/fgene.2021.767590] [Reference Citation Analysis]
6 Wu Y, Zhao H. CTBP1 strengthens the cisplatin resistance of gastric cancer cells by upregulating RAD51 expression. Oncol Lett 2021;22:810. [PMID: 34630717 DOI: 10.3892/ol.2021.13071] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Mu Q, Lv Y, Luo C, Liu X, Huang C, Xiu Y, Tang L. Research Progress on the Functions and Mechanism of circRNA in Cisplatin Resistance in Tumors. Front Pharmacol 2021;12:709324. [PMID: 34566636 DOI: 10.3389/fphar.2021.709324] [Cited by in F6Publishing: 4] [Reference Citation Analysis]